Thomas Hope, MD

UCSF, San Francisco
School of Medicine

 Nuclear Medicine

NET Symposium Program Committee

Dr. Hope’s primary research focus is on novel imaging agents. He is the principle investigator on the Ga-68 DOTA-TOC IND at UCSF and the Ga-68 HBED-CC PSMA IND at UCSF. He has combined his interest in MR imaging with PET in the simultaneous modality PET/MRI, helping lead the development of the clinical PET/MRI program. Additionally, he is developing the PRRT (peptide receptor radionuclide therapy) program for neuroendocrine tumors at UCSF.

Dr. Hope has published 30 peer-reviewed articles, including 17 first author publications.